liveonearth (liveonearth) wrote,
liveonearth
liveonearth

GSK pays 3 BILLION $$$ fine for lying about drugs

And you thought you could trust a pharmaceutical company? LOL, probably not, you're smarter than that. GSK promoted off-label uses for two drugs, and didn't reveal safety information on another. (They make lots of vaccines, in case you don't know.) Scientific research done by corporations with a profit motive is guaranteed to be reported in a biased way. This will be the biggest fine ever paid by a drug company, and it might even big enough to serve as a disincentive to standard pharmaceutical policies of disinformation. Too bad that these drugs are what insurance will pay for, and not preventative care. And too bad that nobody goes to jail; the decisionmakers of GSK get to hide behind the corporation. Maybe their bonuses will get cut. I can only hope. I know there are humans behind these decisions. Humans with greed and pride where their love and compassion ought to be.

NEWS
http://www.mercurynews.com/business/ci_20990296/glaxosmithkline-pay-largest-health-care-fraud-fine-history?source=rss
http://bottomline.msnbc.msn.com/_news/2012/07/02/12525279-glaxosmithkline-settles-fraud-case-for-3-billion?lite
http://www.cbc.ca/news/health/story/2012/07/02/health-glaxosmithkline-fraud-settlement.html
Tags: corporations, corruption, drugs, healthcare, insurance, pharmaceuticals, public health, science, vaccines
Subscribe

  • QotD: Truth out of season

    “Truth out of season bears no fruit.” —Meng-tzu, Chinese philosopher

  • QotD: Think

    Think lightly of yourself and deeply of the world. --Miyamoto Musashi

  • QotD: Privilege of Human Beings

    "Rats and roaches live by competition under the law of supply and demand; it is the privilege of human beings to live under the laws of justice…

  • Post a new comment

    Error

    Comments allowed for friends only

    Anonymous comments are disabled in this journal

    default userpic

    Your reply will be screened

    Your IP address will be recorded 

  • 3 comments